ZETA Pharmaceuticals

Zeta Pharma is an Egyptian pharmaceutical company established in 2015, specializing in the development and manufacturing of high-quality generic medications. The company gained international recognition for its pivotal role in the Egyptian national initiative to eliminate Hepatitis C, producing affordable direct-acting antivirals such as Zeta-Sof and Zeta-Dacla. Zeta Pharma operates a state-of-the-art, GMP-certified manufacturing facility in Sadat City and maintains a diverse product portfolio across therapeutic areas including cardiology, endocrinology, and gastroenterology. The company is focused on expanding its presence in the Middle East and Africa through strategic partnerships and a commitment to international quality standards. Its business model emphasizes accessibility and affordability, aiming to bridge the gap in healthcare provision within emerging markets.